Classifications

• • C—CHEMISTRY; METALLURGY
  • C07—ORGANIC CHEMISTRY
  • C07D—HETEROCYCLIC COMPOUNDS
  • C07D277/00—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
  • C07D277/02—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings
  • C07D277/20—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
  • C07D277/32—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
  • C07D277/38—Nitrogen atoms
  • C07D277/44—Acylated amino or imino radicals
  • C07D277/46—Acylated amino or imino radicals by carboxylic acids, or sulfur or nitrogen analogues thereof
• • A—HUMAN NECESSITIES
  • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
  • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
  • A61K31/00—Medicinal preparations containing organic active ingredients
  • A61K31/33—Heterocyclic compounds
  • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
  • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
  • A61K31/425—Thiazoles
  • A61K31/426—1,3-Thiazoles
• • A—HUMAN NECESSITIES
  • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
  • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
  • A61P25/00—Drugs for disorders of the nervous system
• • A—HUMAN NECESSITIES
  • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
  • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
  • A61P25/00—Drugs for disorders of the nervous system
  • A61P25/08—Antiepileptics; Anticonvulsants
• • A—HUMAN NECESSITIES
  • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
  • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
  • A61P25/00—Drugs for disorders of the nervous system
  • A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
• • A—HUMAN NECESSITIES
  • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
  • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
  • A61P25/00—Drugs for disorders of the nervous system
  • A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
  • A61P25/16—Anti-Parkinson drugs
• • A—HUMAN NECESSITIES
  • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
  • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
  • A61P25/00—Drugs for disorders of the nervous system
  • A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
• • A—HUMAN NECESSITIES
  • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
  • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
  • A61P25/00—Drugs for disorders of the nervous system
  • A61P25/24—Antidepressants
• • A—HUMAN NECESSITIES
  • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
  • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
  • A61P25/00—Drugs for disorders of the nervous system
  • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
• • A—HUMAN NECESSITIES
  • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
  • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
  • A61P9/00—Drugs for disorders of the cardiovascular system
• • A—HUMAN NECESSITIES
  • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
  • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
  • A61P9/00—Drugs for disorders of the cardiovascular system
  • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

• Health & Medical Sciences (AREA)
• Chemical & Material Sciences (AREA)
• Organic Chemistry (AREA)
• Engineering & Computer Science (AREA)
• Bioinformatics & Cheminformatics (AREA)
• Life Sciences & Earth Sciences (AREA)
• Pharmacology & Pharmacy (AREA)
• Veterinary Medicine (AREA)
• Public Health (AREA)
• General Health & Medical Sciences (AREA)
• Medicinal Chemistry (AREA)
• Animal Behavior & Ethology (AREA)
• General Chemical & Material Sciences (AREA)
• Neurosurgery (AREA)
• Neurology (AREA)
• Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
• Chemical Kinetics & Catalysis (AREA)
• Biomedical Technology (AREA)
• Psychiatry (AREA)
• Epidemiology (AREA)
• Psychology (AREA)
• Pain & Pain Management (AREA)
• Heart & Thoracic Surgery (AREA)
• Cardiology (AREA)
• Urology & Nephrology (AREA)
• Vascular Medicine (AREA)
• Hospice & Palliative Care (AREA)
• Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
• Thiazole And Isothizaole Compounds (AREA)
• Plural Heterocyclic Compounds (AREA)

Applications Claiming Priority (3)

Publications (1)

Family

ID=34524309

Family Applications (1)

Country Status (28)

Families Citing this family (17)

Family Cites Families (12)

• 2004
  • 2004-10-08 TW TW093130498A patent/TW200524887A/zh unknown
  • 2004-10-21 AR ARP040103822A patent/AR047621A1/es not_active Application Discontinuation
  • 2004-10-25 SI SI200430225T patent/SI1682129T1/sl unknown
  • 2004-10-25 KR KR1020067008181A patent/KR20060093726A/ko not_active Ceased
  • 2004-10-25 EA EA200801734A patent/EA200801734A1/ru unknown
  • 2004-10-25 CA CA002542816A patent/CA2542816A1/en not_active Abandoned
  • 2004-10-25 EP EP07102639A patent/EP1803455A1/en not_active Withdrawn
  • 2004-10-25 JP JP2006535952A patent/JP2007509083A/ja not_active Withdrawn
  • 2004-10-25 RS YUP-2006/0289A patent/RS20060289A/sr unknown
  • 2004-10-25 EA EA200600860A patent/EA010790B1/ru not_active IP Right Cessation
  • 2004-10-25 MX MXPA06004436A patent/MXPA06004436A/es active IP Right Grant
  • 2004-10-25 ME MEP-67/08A patent/MEP6708A/xx unknown
  • 2004-10-25 AU AU2004283019A patent/AU2004283019A1/en not_active Abandoned
  • 2004-10-25 HR HR20070194T patent/HRP20070194T3/xx unknown
  • 2004-10-25 BR BRPI0415661-7A patent/BRPI0415661A/pt not_active IP Right Cessation
  • 2004-10-25 WO PCT/DK2004/000733 patent/WO2005039572A1/en not_active Ceased
  • 2004-10-25 DE DE602004004925T patent/DE602004004925T2/de not_active Expired - Fee Related
  • 2004-10-25 EP EP04762951A patent/EP1682129B1/en not_active Expired - Lifetime
  • 2004-10-25 PL PL04762951T patent/PL1682129T3/pl unknown
  • 2004-10-25 ES ES04762951T patent/ES2279414T3/es not_active Expired - Lifetime
  • 2004-10-25 AT AT04762951T patent/ATE354365T1/de not_active IP Right Cessation
  • 2004-10-25 SG SG200807988-1A patent/SG147472A1/en unknown
  • 2004-10-25 PT PT04762951T patent/PT1682129E/pt unknown
  • 2004-10-25 DK DK04762951T patent/DK1682129T3/da active
• 2005
  • 2005-12-20 US US11/312,661 patent/US20060154974A1/en not_active Abandoned
• 2006
  • 2006-03-20 IS IS8364A patent/IS8364A/is unknown
  • 2006-04-25 IL IL175189A patent/IL175189A0/en unknown
  • 2006-04-25 CO CO06039105A patent/CO5690582A2/es not_active Application Discontinuation
  • 2006-05-26 NO NO20062417A patent/NO20062417L/no not_active Application Discontinuation
• 2007
  • 2007-04-19 CY CY20071100529T patent/CY1106526T1/el unknown
• 2008
  • 2008-12-19 US US12/339,438 patent/US20090247593A1/en not_active Abandoned

Also Published As

Similar Documents